BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9671341)

  • 1. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
    Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
    J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
    Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
    J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
    Miller MJ; Molla PM
    Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
    Sernyak MJ; Gulanski B; Rosenheck R
    J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and associated diabetes mellitus.
    Popli AP; Konicki PE; Jurjus GJ; Fuller MA; Jaskiw GE
    J Clin Psychiatry; 1997 Mar; 58(3):108-11. PubMed ID: 9108812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus associated with clozapine therapy.
    Wehring H; Alexander B; Perry PJ
    Pharmacotherapy; 2000 Jul; 20(7):844-7. PubMed ID: 10907975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes mellitus after treatment with clozapine].
    Brugman NJ; Cohen D; de Vries RH
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics.
    Procyshyn RM; Ihsan N; Thompson D
    Int Clin Psychopharmacol; 2001 Sep; 16(5):291-4. PubMed ID: 11552773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    Nord J Psychiatry; 2017 Oct; 71(7):496-502. PubMed ID: 28632422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
    Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
    Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.
    Wysokiński A
    Diabetes Metab Syndr; 2014; 8(4):236-41. PubMed ID: 25311817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa.
    Erasmus RT; Blanco Blanco E; Okesina AB; Matsha T; Gqweta Z; Mesa JA
    S Afr Med J; 2001 Feb; 91(2):157-60. PubMed ID: 11288399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.